ABSTRACT
Objective To investigate the clinicopathological characteristics and risk factors for recurrence of epithelial borderline ovarian tumors (BOT). Methods The data of 210 BOT patients from January 2001 to December 2015 in Shanxi Provincial Cancer Hospital were retrospectively analyzed. Results The mean age of 210 BOT patients was(41±16)years old including 68.1 %(143/210)patients of stage IA,and 31.9 %(67/210)patients>stage IA.Twenty-three patients had recurrence and the recurrence rate was 11.3 % (23/204); Univariate analysis showed that there were statistically significant differences in relapse rate among BOT patients with regard to age (P =0.007), stage (P =0.009), microemulsion pattern (P =0.024) and operative mode(P= 0.025). Multivariate logistic regression analysis showed that micropapillary pattern (OR=0.153, 95 % CI 0.044-0.535), the age (≤40 years old) (OR= 0.245, 95 % CI 0.088-0.686) and high stage (OR=3.502, 95 % CI 1.360-9.020) were risk factors for recurrence in BOT patients. Conclusions BOT mainly occurs in young women of child-bearing age,who are at an early stage and have a good prognosis. The patients who belong to 40 years old or below, the staging >ⅠAand micropapillary pattern would be easy to recur.
ABSTRACT
Borderline ovarian tumor (BOT) is a kind of ovarian epithelial tumors with low malignant potency and favorable prognosis, accounting for 10%-20%of ovarian epithelial tumors. BOT occurs mainly in young female during child-bearing period, which may have bad effects on the recurrence and reproductive function in the following treatment. BOT bears some similarities to the clinical features of infiltrating ovarian tumor, however, there is a significant difference in the treatment and prognosis between them. This paper summarizes the progress of BOT, including diagnosis, treatment strategy and prognosis.
ABSTRACT
Borderline ovarian tumor (BOT) is a kind of ovarian epithelial tumors with low malignant potency and favorable prognosis, accounting for 10%-20%of ovarian epithelial tumors. BOT occurs mainly in young female during child-bearing period, which may have bad effects on the recurrence and reproductive function in the following treatment. BOT bears some similarities to the clinical features of infiltrating ovarian tumor, however, there is a significant difference in the treatment and prognosis between them. This paper summarizes the progress of BOT, including diagnosis, treatment strategy and prognosis.